Zivo Bioscience

Zivo Bioscience Quick Ratio

The Quick Ratio (Acid Test) of Zivo Bioscience (ZIVO) as of Nov 3, 2026 is 0.03. In the previous year, Quick Ratio (Acid Test) was 0.49 — a change of -93.13% (lower).

Quick Ratio

0.03

YoY

-93.13%

Last updated:

Quick Ratio (Acid Test) of Zivo Bioscience is 2025 0.03 . Quick Ratio (Acid Test) of Zivo Bioscience was 2024 0.49 . It decreases by -93.13% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zivo Bioscience Stock analysis

What does Zivo Bioscience do? Zivo Bioscience, Inc. generates revenue by developing and selling natural bioactive ingredients derived from its proprietary algal strains to manufacturers in the animal, human, dietary supplement, and medical food industries. The company focuses on research and identification of bioactive molecules for use in products targeting autoimmune and inflammatory response modulation. It also develops and sells health optimization tests that help users identify future health risks and personalize their wellness approaches. The firm manufactures algal products and derivatives through its proprietary platforms, serving both human and animal health markets. The company's primary customers include manufacturers of dietary supplements, medical foods, and pharmaceuticals seeking natural ingredients for their formulations. These manufacturers utilize Zivo's bioactive molecules to create products that address autoimmune and inflammatory conditions. Additionally, the company's health optimization tests are marketed to consumers interested in proactive health management, offering personalized insights based on bioactive data. Zivo's product portfolio spans from raw ingredients to finished test kits, all derived from its algal and bacterial host cultures. Zivo Bioscience's revenue streams are built around its proprietary algal strains, which serve as the foundation for all its products. The company's focus on natural compounds and bioactive molecules allows it to target both the supplement and medical food sectors, as well as the emerging market for personalized health diagnostics. By leveraging its research capabilities, Zivo provides specialized ingredients and diagnostic tools that cater to specific health challenges, particularly those related to immune response and inflammation. The firm's business model centers on creating value through scientific innovation in natural product development and health monitoring technologies. Zivo Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zivo Bioscience stock

Quick Ratio (Acid Test) of Zivo Bioscience is 0.03 in 2025.

Quick Ratio (Acid Test) of Zivo Bioscience changed from 0.49 to 0.03, representing a -93.13% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Quick Ratio (Acid Test) Zivo Bioscience since 2006 – with annual values, charts, and detailed analysis.

The Quick Ratio measures liquidity by comparing liquid assets to current liabilities, excluding inventory. It is a more conservative measure than the current ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Quick Ratio (Acid Test)'s Zivo Bioscience with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Zivo Bioscience

All Key Metrics — Zivo Bioscience